RHINOMED’S MUTE WINS US DRUG STORE NEWS 2019 RETAIL EXCELLENCE (REX) AWARD HIGHLIGHTS: ● Rhinomed’s nasal dilator (Mute) awarded prestigious US retail pharmacy award ● Mute first Australian owned and listed product to receive REX Award ● Adoption and distribution of Mute across leading US pharmacy chains reaches ~9,000 (11,000 globally) ● Mute one of the fastest growing sleep and snoring product in the US1 ● Rhinomed to unveil two new OTC nasal products targeting decongestion and sleeplessness in next two months March 18, 2019. Melbourne, Australia Rhinomed (ASX:RNO), a leader in nasal technology and the makers of Mute™, is pleased to inform investors that it has become the first Australian owned and listed product to receive the prestigious Drug Store News Retail Excellence (REX) Award in the OTC (Over the Counter) category. As the trusted voice of the North American retail pharmacy marketplace, Drug Store News (DSN) is the number one source of news, knowledge, and networking in the industry.
Drug Store News said: “Drug Store News REX Awards honour those manufacturers who have made a difference in their respective industries during the last several years, be it with innovative products, merchandising or marketing.”
The Over the Counter Category (OTC) is one of the largest and most competitive categories in the North American retail market. Selected for being an industry disruptor over the last two years Rhinomed’s Mute™ technology not only offers a revolutionary approach to breathing, snoring and sleep issues, but it is extremely simple, accessible and cost effective, which is why it has been one of the fastest growing brands in this category.
Rhinomed CEO, Michael Johnson, said: "We are focused on changing the way the world breathes and sleeps. We know that if we can get people to breathe more, snore less and sleep better we can help them to live better, healthier lives. It is a great honour for an Australian based company to receive the REX award from DSN and to be recognized by our peers for our continued growth and innovation in one of the toughest markets in the world and one of the most highly competitive categories - the OTC category. Mute has made massive gains against some of the biggest and strongest brands in the world and this is a clear demonstration of that success."
Rhinomed is focused on its mission of radically improving the way people breathe, sleep, maintain their health and take medication. The company is continuing to deliver on this strategy of disrupting the market with exciting innovation through its Mute offering and later this year will launch an entirely new range of nasal technology. Two new revolutionary products will be released. One offering fast acting and up to eight hours of relief from nasal congestion and the other providing relief to the millions who struggle to get to sleep each night.